RxDoctor Payments Data

Audina Berrocal, MD

Retina Specialist · Miami, FLNPI 1437192135

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $167,267 of the $209,943 with a category attached, or 79.7%. 20 manufacturers reported payments, led by Alcon at 53.6% of the total. Reporting peaked in 2019 at $51,836 and has fallen 85.9% since, to $7,310 in 2025. Among retina specialist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$209,943in general payments, 2019–2025

Across 187 payments — averaging $1122.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$112K
  • Carl Zeiss Meditec, Inc.$21K
  • Alcon Research LLC$19K
  • F. Hoffmann-la Roche AG$16K
  • Dutch Ophthalmic, USA$15K
  • AbbVie$7K
  • plus $18K from 14 others

What the payments were for

  • Consulting fees$167,26780%
  • Speaking & faculty fees$18,8509%
  • Travel & lodging$13,8007%
  • Food & beverage$10,0155%
  • Gifts$100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$209,943 in reported general payments places this provider in the 95th percentile of 118 retina specialist providers in Florida.

See all retina specialist providers in Florida

Medicare billing

Part B allowed, 2024
$85,116
Medicare patients
184
Services billed
1,119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate37$1,531
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha47$556
ErythromycinErythromycin Base11$444
Atropine Sulfate11$443
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat23$231
Brimonidine Tartrate23$205
Latanoprost32$119
Timolol Maleate18$87

Paid to pharmacies, not to this prescriber.

Other retina specialist in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →